glutathione synthetase deficiency prevalence dysregulation and the etiology and progression of human diseases Frontiers | Glutathione and mitochondria

A compound can be widely discussed and still rest almost entirely on cell-culture and animal data, with little or no controlled human evidence

In accord with the aforementioned pathological studies in iLBD, a study examining inflammatory changes in the SNc by [ 11 C]PK11195 18 kDa translocator protein (TSPO) PET found increased microglial activation in iRBD, suggesting early immunological changes in the midbrain [120]

Extrapituitary expression of GH has been detected in the human retina and vitreous fluid, 94 and GH has been demonstrated to directly stimulate the proliferation of human retinal microvascular endothelial cells in vitro

In the studies that proofed tumor growth inhibition by a KD fed ad libitum, there was a significant increase in KB levels, but not necessarily decreases in blood glucose levels or body weight

[1] What the best bioavailability trial actually showed The most rigorous test of this question was a six-month, randomized, double-blind, placebo-controlled trial of oral glutathione at 250 or 1000 mg/day in 54 non-smoking adults